These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 901452)
1. N delta-(phosphonacetyl)-L-ornithine, a potent transition state analogue inhibitor of ornithine carbamoyltransferase. Mori M; Aoyagi K; Tatibana M; Ishikawa T; Ishii H Biochem Biophys Res Commun; 1977 Jun; 76(3):900-4. PubMed ID: 901452 [No Abstract] [Full Text] [Related]
2. Synthesis and properties of delta-N-(phosphonacetyl)-L-ornithine. A transition-state analog inhibitor of ornithine transcarbamylase. Hoogenraad NJ Arch Biochem Biophys; 1978 May; 188(1):137-44. PubMed ID: 677887 [No Abstract] [Full Text] [Related]
3. The inactivation of ornithine transcarbamoylase by N delta-(N'-sulpho-diaminophosphinyl)-L-ornithine. Templeton MD; Mitchell RE; Sullivan PA; Shepherd MG Biochem J; 1985 Jun; 228(2):347-52. PubMed ID: 4015624 [TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of the L-ornithine transcarbamoylase from Pseudomonas savastanoi pv. phaseolicola that is resistant to the transition state analogue (R)-N delta-(N'-sulfodiaminophosphinyl)-L-ornithine. Templeton MD; Reinhardt LA; Collyer CA; Mitchell RE; Cleland WW Biochemistry; 2005 Mar; 44(11):4408-15. PubMed ID: 15766270 [TBL] [Abstract][Full Text] [Related]
5. Purification and properties of porcine liver ornithine transcarbamylase. Koger JB; Howell RG; Kelly M; Jones EE Arch Biochem Biophys; 1994 Mar; 309(2):293-9. PubMed ID: 8135541 [TBL] [Abstract][Full Text] [Related]
6. Kinetics and equilibrium of the inactivation of ornithine transcarbamylases by pyridoxal 5'-phosphate. Marshall M; Cohen PP J Biol Chem; 1977 Jun; 252(12):4276-86. PubMed ID: 16927 [No Abstract] [Full Text] [Related]
7. Effect of the transition-state analogue, delta-N-(phosphonacetyl)-L-ornithine on citrulline synthesis in isolated rat-liver mitochondria and on urea synthesis in isolated rat hepatocytes. Hoogenraad NJ; Sutherland TM; Howlett GJ Eur J Biochem; 1979 Oct; 100(1):309-15. PubMed ID: 488100 [No Abstract] [Full Text] [Related]
8. The illicit permeation of N-delta-phosphonoacetyl-L-ornithine under the form of a tripeptide. Selective inhibition in vivo of Escherichia coli L-ornithine carbamoyltransferase [proceedings]. Penninckx M; Gigot D Arch Int Physiol Biochim; 1979 Feb; 87(1):198-9. PubMed ID: 92272 [No Abstract] [Full Text] [Related]
9. Mitochondrial carbamyl phosphate and citrulline synthesis at high matrix acetylglutamate. Cohen NS; Cheung CW; Kyan FS; Jones EE; Raijman L J Biol Chem; 1982 Jun; 257(12):6898-907. PubMed ID: 7085611 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of a peptide form of N-delta-(phosphonoacetyl)-L-ornithine. Its antibacterial effect through the specific inhibition of Escherichia coli L-ornithine carbamoyltransferase. Penninckx M; Gigot D J Biol Chem; 1979 Jul; 254(14):6392-6. PubMed ID: 376531 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of inactivation of ornithine transcarbamoylase by Ndelta -(N'-Sulfodiaminophosphinyl)-L-ornithine, a true transition state analogue? Crystal structure and implications for catalytic mechanism. Langley DB; Templeton MD; Fields BA; Mitchell RE; Collyer CA J Biol Chem; 2000 Jun; 275(26):20012-9. PubMed ID: 10747936 [TBL] [Abstract][Full Text] [Related]
12. An essential lysine in the substrate-binding site of ornithine carbamoyltransferase. Valentini G; De Gregorio A; Di Salvo C; Grimm R; Bellocco E; Cuzzocrea G; Iadarola P Eur J Biochem; 1996 Jul; 239(2):397-402. PubMed ID: 8706746 [TBL] [Abstract][Full Text] [Related]
13. Ornithine carbamoyltransferase deficiency. A new variant with subnormal enzyme activity. Rabier D; Benoit A; Petit F; Chekoury A; Bonnefont JP; Saudubray JM; Kamoun P Clin Chim Acta; 1989 Dec; 186(1):25-9. PubMed ID: 2612006 [TBL] [Abstract][Full Text] [Related]
14. N5-phosphonoacetyl-L-ornithine (PALO): a convenient synthesis and investigation of influence on regulation of amino acid biosynthetic genes in Saccharomyces cerevisiae. Johnson B; Steadman R; Patefield KD; Bunker JJ; Atkin AL; Dussault P Bioorg Med Chem Lett; 2011 Apr; 21(8):2351-3. PubMed ID: 21421312 [TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of ornithine decarboxylase by beta,gamma unsaturated substrate analogs. Relyea N; Rando RR Biochem Biophys Res Commun; 1975 Nov; 67(1):392-8. PubMed ID: 1201030 [No Abstract] [Full Text] [Related]
16. Evidence of carbamoylphosphate induced conformational changes upon binding to human ornithine carbamoyltransferase. De Gregorio A; Risitano A; Capo C; Criniò C; Petruzzelli R; Desideri A Biochem Mol Biol Int; 1999 Jun; 47(6):965-70. PubMed ID: 10410242 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and interaction with Escherichia coli L-ornithine carbamolytransferase of two potential transition-state analogues. Penninckx M; Gigot D FEBS Lett; 1978 Apr; 88(1):94-6. PubMed ID: 346377 [No Abstract] [Full Text] [Related]
19. Utilization of conformational flexibility in enzyme action-linkage between binding, isomerization, and catalysis. Goldsmith JO; Kuo LC J Biol Chem; 1993 Sep; 268(25):18481-4. PubMed ID: 8360150 [TBL] [Abstract][Full Text] [Related]
20. Effect of dimethylnitrosamine upon carbamoyl phosphate and ornithine utilization in rat liver. Karsai T; Rády P; Nagy Z; Szondy Z Anticancer Res; 1985; 5(4):441-4. PubMed ID: 2864015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]